Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study
- PMID: 27592170
- DOI: 10.1159/000448341
Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study
Abstract
Background: Hyperkalemia is common in patients receiving maintenance hemodialysis. However, few studies have examined the association between serum potassium level and mortality.
Methods: This study used annual cohorts of hemodialysis patients during 2007-2010. To determine hyperkalemia prevalence, monthly hyperkalemia was defined as serum potassium level ≥5.5 mEq/l; prevalence was calculated as a ratio of hyperkalemia episodes to follow-up time, reported separately by long and short interdialytic interval. To determine the impact of hyperkalemia on mortality, patients in the 2010 cohort were followed from first potassium measurement until death or a censoring event; hyperkalemia was defined, sequentially, by potassium levels 5.5-6.0 mEq/l at 0.1 mEq/l intervals. Time-dependent Cox proportional hazards modeling was used to estimate the association between hyperkalemia and mortality.
Results: The 4 annual cohorts ranged from 28,774 to 36,888 patients. Mean age was approximately 63 years, about 56% were men, 51% were white and 44% had end-stage renal disease caused by diabetes. Hyperkalemia prevalence was consistently estimated at 16.3-16.8 events per 100 patient-months. Prevalence on the day after the long interdialytic interval was 2.0-2.4 times as high as on the day after the short interval. Hyperkalemia, when defined as serum potassium ≥5.7 mEq/l, was associated with all-cause mortality (adjusted hazards ratio (AHR) 1.13, 95% CI 1.01-1.28, p = 0.037, vs. <5.7 mEq/l) after adjustment. AHRs increased progressively as the hyperkalemia threshold increased, reaching 1.37 (95% CI 1.16-1.62, p < 0.0001) for ≥6.0 mEq/l.
Conclusions: The long interdialytic interval was associated with increased likelihood of hyperkalemia. Hyperkalemia was associated with all-cause mortality beginning at serum potassium ≥5.7 mEq/l; mortality risk estimates increased ordinally through ≥6.0 mEq/l, suggesting a threshold at which serum potassium becomes substantially more dangerous.
© 2016 S. Karger AG, Basel.
Similar articles
-
Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.PLoS One. 2015 Oct 6;10(10):e0139886. doi: 10.1371/journal.pone.0139886. eCollection 2015. PLoS One. 2015. PMID: 26440515 Free PMC article.
-
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval.Am J Kidney Dis. 2017 Jul;70(1):21-29. doi: 10.1053/j.ajkd.2016.10.024. Epub 2017 Jan 19. Am J Kidney Dis. 2017. PMID: 28111027
-
Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction.Am J Med. 2016 Aug;129(8):858-65. doi: 10.1016/j.amjmed.2016.03.008. Epub 2016 Apr 7. Am J Med. 2016. PMID: 27060233 Free PMC article.
-
Potassium balance in dialysis patients.Semin Dial. 2013 Sep-Oct;26(5):597-603. doi: 10.1111/sdi.12123. Semin Dial. 2013. PMID: 24073843 Review.
-
The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review.Ren Fail. 2021 Dec;43(1):241-254. doi: 10.1080/0886022X.2020.1871012. Ren Fail. 2021. PMID: 33478329 Free PMC article.
Cited by
-
Seasonal variation of serum potassium in hemodialysis patients: myth or reality? A narrative review of literature.Ren Fail. 2024 Dec;46(2):2359640. doi: 10.1080/0886022X.2024.2359640. Epub 2024 Jun 4. Ren Fail. 2024. PMID: 38832483 Free PMC article. Review.
-
Prevalence, practice pattern, and mortality of hyperkalemia in Chinese patients undergoing hemodialysis in the visualize HD study.Sci Rep. 2025 Jul 1;15(1):22405. doi: 10.1038/s41598-025-92609-1. Sci Rep. 2025. PMID: 40596462 Free PMC article.
-
A nomogram to predict hyperkalemia in patients with hemodialysis: a retrospective cohort study.BMC Nephrol. 2022 Nov 1;23(1):351. doi: 10.1186/s12882-022-02976-4. BMC Nephrol. 2022. PMID: 36319967 Free PMC article. Clinical Trial.
-
Management of Cardiovascular Diseases in Chronic Hemodialysis Patients.Rev Cardiovasc Med. 2023 Jun 29;24(7):185. doi: 10.31083/j.rcm2407185. eCollection 2023 Jul. Rev Cardiovasc Med. 2023. PMID: 39077004 Free PMC article. Review.
-
Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.J Transl Med. 2022 Jul 25;20(1):333. doi: 10.1186/s12967-022-03530-4. J Transl Med. 2022. PMID: 35879718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical